Dianthus Therapeutics | MGTA - Debitur Perdagangan





Debitur Perdagangan Perubahan Tanggal
Akebia Therapeutics USD 47.03M 19.19M 2025-12
Alaunos Therapeutics USD 2K 0 2025-06
Avita Medical AUD 9.11M 2.26M 2025-12
Celltrion KRW 1.51T 128.69B 2025-09
Cspc Pharmaceutical CNY 8.85B 769.12M 2025-06
Deva Holding AS TRY 3.03B 343.23M 2023-09
Dianthus Therapeutics USD 52K 4.95M 2025-12
Divis Laboratories Ltd INR 26.28B 1.16B 2025-09
IQVIA Holdings USD 3.43B 113M 2025-12
Kangmei Pharma CNY 3.15B 295.48M 2025-09
Knight Therapeutics CAD 175.54M 17.32M 2025-09
Laboratorios Farma EUR 143.38M 16.93M 2023-12
Malin Corporation EUR 500K 300K 2024-12
Medical Developments International AUD 7.48M 174K 2025-12
Moderna USD 184M 862M 2025-12
Neuren Pharmaceuticals AUD 26.54M 5.83M 2025-12
Organigram Holdings CAD 64.86M 7.31M 2025-09
Organon & Co USD 1.48B 0 2025-09
Ovoca Bio EUR 447K 113K 2022-06
Pharma Mar EUR 60.6M 18.83M 2025-12
Qiagen NV USD 402.61M 9.05M 2025-12
Revvity USD 744.67M 64.41M 2025-12
Sartorius EUR 344.7M 48.5M 2025-09
Sino Biopharmaceutical CNY 8.45B 3.18B 2025-06
Tectonic Therapeutic USD 0 270K 2023-12
Tilray USD 121.49M 18.12M 2025-03
Viatris USD 3.03B 340.3M 2025-12
Xeris Pharmaceuticals USD 51.05M 2.7M 2025-12
Zz Pientze Pharmaceu CNY 1.12B 222.78M 2025-09